APA (7th ed.) Citation

RE, P., SJ, B., CA, N., MF, N., & R, G. (2022). Safety of in utero exposure to maternal IBD pharmacotherapies. Nature reviews. Gastroenterology & hepatology, 19(4), 213. https://doi.org/10.1038/s41575-021-00572-9

Chicago Style (17th ed.) Citation

RE, Prentice, Bell SJ, Nold-Petry CA, Nold MF, and Goldberg R. "Safety of in Utero Exposure to Maternal IBD Pharmacotherapies." Nature Reviews. Gastroenterology & Hepatology 19, no. 4 (2022): 213. https://doi.org/10.1038/s41575-021-00572-9.

MLA (9th ed.) Citation

RE, Prentice, et al. "Safety of in Utero Exposure to Maternal IBD Pharmacotherapies." Nature Reviews. Gastroenterology & Hepatology, vol. 19, no. 4, 2022, p. 213, https://doi.org/10.1038/s41575-021-00572-9.